[Cryoplasma-antienzymatic therapy for aspiration pneumonia in neonatal infants with esophageal atresia].
The results of treatment were analyzed in 75 neonatal infants with aspiration pneumonia in the presence of esophageal atresia. The analysis of the hemostatic system in this category of patients has shown that changes occurred as hypocoagulation with its pronounced activation. Cryoplasma transfusion in combination with an antienzymatic drug improved the result of treatment in neonatal infants with aspiration pneumonia in the presence of esophageal atresia, reduced the duration of treatment at an intensive care unit, the incidence of postoperative complications, and mortality rates.
Kozhevnikov
V A
VA
Zav'ialov
A E
AE
Meshkov
M V
MV
Azarov
E N
EN
Chuĭkov
E N
EN
Dorofeev
M Iu
MIu
Tereniuk
E L
EL
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology / Q000628:therapy; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D004933:Esophageal Atresia / Q000150:complications* / Q000601:surgery; D005260:Female; D005947:Glucose / Q000008:administration & dosage; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010951:Plasma Exchange / Q000379:methods*; D011015:Pneumonia, Aspiration / Q000097:blood / Q000209:etiology / Q000628:therapy*; D012121:Respiration, Artificial
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D007611:Aprotinin; D005947:Glucose